Glutamine and acute illness.
This is a literature review over a time period of the past 2 years concerning glutamine in clinical nutrition. Emphasis is put upon studies of glutamine in clinical settings, but a brief overview of the large range of literature over the role of glutamine in various experimental settings is also included. The most interesting concept for the past 2 years is the suggestion to use plasma glutamine concentration at admission to the intensive care unit as a prognostic marker and as a possible indicator for indication of glutamine supplementation.
Wernerman
Jan
J
Department of Anesthesiology and Intensive Care, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden. jan.werneman@hs.se
D000208:Acute Disease; D003422:Critical Care / Q000379:methods*; D016638:Critical Illness / Q000628:therapy*; D005973:Glutamine / Q000097:blood* / Q000494:pharmacology*; D006801:Humans; D018529:Nutritional Support; D011237:Predictive Value of Tests
D005973:Glutamine